Latest News & Features
Big Pharma
The England and Wales High Court has refused Pfizer subsidiary Pharmacia’s request to stay Actavis’s patent revocation action against it. 17 July 2014
Asia
The Mumbai High Court has upheld India-based Natco Pharma’s compulsory licence on Bayer’s kidney cancer drug Nexavar (sorafenib). 16 July 2014
Americas
The Canadian government has responded to Eli Lilly’s complaint that recent decisions to invalidate two Lilly patents violated the North American Free Trade Agreement, saying that Lilly’s challenge is “wholly without merit”, and should be dismissed. 15 July 2014
Americas
The UK government’s “patent box” was a key factor behind the multi-billion pound cash-plus-shares takeover bid for the Irish-headquartered global specialty biopharmaceutical company Shire by US-based drugs company AbbVie. 14 July 2014
Americas
Pfizer is facing three class actions that allege the pharmaceutical company improperly obtained a patent covering its arthritis drug Celebrex (celecoxib) and used it to force generic drug makers into settlements that delay their entry into the market, Law360 has reported. 10 July 2014
article
Johnson & Johnson’s senior vice president of IP, Phil Johnson, may be out of the running for the top job at the US Patent and Trademark Office (USPTO) as the Obama administration reconsiders its choice for the role, insiders have told The Wall Street Journal. 10 July 2014
Americas
French pharmaceutical company Sanofi has sued Eli Lilly for infringing seven patents that cover its blockbuster diabetes drug Lantus (insulin glargine). 10 July 2014
Americas
US-based Acorda Therapeutics has sued Actavis for infringing four patents covering its multiple sclerosis (MS) drug Ampyra (dalfampridine). 9 July 2014
article
Tennessee-based law firm Stites & Harbison PLLC has expanded its IP and technology practice with the hire of life sciences partners Kelly Hollowell and Justin McNaughton. 9 July 2014
Asia
Australian biotechnology company NeuClone has signed an agreement with vaccine maker the Serum Institute of India to manufacture and supply ten biosimilar monoclonal antibody drugs around the world. 8 July 2014